Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PODS
NCT06132685Phase 2Recruiting
- Sponsor
- Emory University
- Start
- Jan 2025
- Primary completion
- Jul 2027
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
A Phase 2 trial of dexamethasone in brain tumor, high-grade glioma (HGG), low-grade glioma (LGG), brain metastasis (BM), meningioma, sponsored by Emory University. Started Jan 2025; status: recruiting.
02
Drugs
dexamethasone
03
Conditions
brain tumorhigh-grade glioma (HGG)low-grade glioma (LGG)brain metastasis (BM)meningioma
Beyond the preview
Go deeper on NCT06132685.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06132685.